Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction.

Thrombin-induced barrier dysfunction of pulmonary endothelial monolayer is associated with dramatic cytoskeletal reorganization, activation of actomyosin contraction, and gap formation. Phosphorylation of regulatory myosin light chains (MLC) is a key mechanism of endothelial cell (EC) contraction and barrier dysfunction, which is triggered by Ca(2+)/calmodulin-dependent MLC kinase (MLCK) and Rho-associated kinase (Rho-kinase). The role of MLCK in EC barrier regulation has been previously described; however, Rho-mediated pathway in thrombin-induced pulmonary EC dysfunction is not yet precisely characterized. Here, we demonstrate that thrombin-induced decreases in transendothelial electrical resistance (TER) indicating EC barrier dysfunction are universal for human and bovine pulmonary endothelium, and involve membrane translocation and direct activation of small GTPase Rho and its downstream target Rho-kinase. Transient Rho membrane translocation coincided with translocation of upstream Rho activator, guanosine nucleotide exchange factor p115-RhoGEF. Rho mediated activation of downstream target, Rho-kinase induced phosphorylation of the EC MLC phosphatase (MYPT1) at Thr(686) and Thr(850), resulting in MYPT1 inactivation, accumulation of diphospho-MLC, actin remodeling, and cell contraction. The specific Rho-kinase inhibitor, Y27632, abolished MYPT1 phosphorylation, MLC phosphorylation, significantly attenuated stress fiber formation and thrombin-induced TER decrease. Furthermore, expression of dominant-negative Rho and Rho-kinase abolished thrombin-induced stress fiber formation and MLC phosphorylation. Our data, which provide comprehensive analysis of Rho-mediated signal transduction in pulmonary EC, demonstrate involvement of guanosine nucleotide exchange factor, p115-RhoGEF, in thrombin-mediated Rho regulation, and suggest Rho, Rho-kinase, and MYPT1 as potential pharmacological and gene therapy targets critical for prevention of thrombin-induced EC barrier disruption and pulmonary edema associated with acute lung injury.

[1]  E. Van Obberghen-Schilling,et al.  Distinct signals via Rho GTPases and Src drive shape changes by thrombin and sphingosine-1-phosphate in endothelial cells. , 2002, Journal of cell science.

[2]  A. Verin,et al.  Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. , 1995, The American journal of physiology.

[3]  V. Natarajan,et al.  Role of protein kinase C in the regulation of prostaglandin synthesis in human endothelium. , 1992, American journal of respiratory cell and molecular biology.

[4]  R. Bizios,et al.  Thrombin‐induced increase in albumin permeability across the endothelium , 1986, Journal of cellular physiology.

[5]  S. Dudek,et al.  Cytoskeletal regulation of pulmonary vascular permeability. , 2001, Journal of applied physiology.

[6]  R. Wysolmerski,et al.  Involvement of myosin light-chain kinase in endothelial cell retraction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[7]  V. Lokeshwar,et al.  Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. , 2000, The Journal of biological chemistry.

[8]  A. Malik,et al.  Thrombin-induced lung vascular injury. Roles of fibrinogen and fibrinolysis. , 2015, The American review of respiratory disease.

[9]  K. Fujisawa,et al.  p160ROCK, a Rho‐associated coiled‐coil forming protein kinase, works downstream of Rho and induces focal adhesions , 1997, FEBS letters.

[10]  A. Verin,et al.  Regulation of endothelial barrier function by the cAMP-dependent protein kinase. , 2000, Endothelium : journal of endothelial cell research.

[11]  J. Rothstein,et al.  Mechanisms for Reversible Regulation between G13 and Rho Exchange Factors* , 2002, The Journal of Biological Chemistry.

[12]  A. Verin,et al.  Mechanisms of ionomycin-induced endothelial cell barrier dysfunction. , 1997, The American journal of physiology.

[13]  A. Verin,et al.  Diperoxovanadate alters endothelial cell focal contacts and barrier function: role of tyrosine phosphorylation. , 2000, Journal of applied physiology.

[14]  X. Q. Chen,et al.  The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton , 1996, Molecular and cellular biology.

[15]  E. Howard,et al.  Regulation of LPA-promoted myofibroblast contraction: role of Rho, myosin light chain kinase, and myosin light chain phosphatase. , 2000, Experimental cell research.

[16]  S. Narumiya,et al.  Rho effectors and reorganization of actin cytoskeleton , 1997, FEBS letters.

[17]  C. Der,et al.  Rho GTPase-dependent transformation by G protein-coupled receptors , 2001, Oncogene.

[18]  H. Hamm,et al.  Gα Minigenes Expressing C-terminal Peptides Serve as Specific Inhibitors of Thrombin-mediated Endothelial Activation* , 2001, The Journal of Biological Chemistry.

[19]  CeciliaGarlanda,et al.  Heterogeneity of Endothelial Cells , 1997 .

[20]  A. Verin,et al.  Molecular Mechanisms of Thrombin-Induced Endothelial Cell Permeability , 2004, Biochemistry (Moscow).

[21]  G. Mize,et al.  Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells. , 2003, Biochemistry.

[22]  A. Verin,et al.  Microtubule disassembly increases endothelial cell barrier dysfunction: role of MLC phosphorylation. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[23]  M. Simon,et al.  Activation of G12/G13 Results in Shape Change and Rho/Rho-Kinase–mediated Myosin Light Chain Phosphorylation in Mouse Platelets , 1999, The Journal of cell biology.

[24]  C. Garlanda,et al.  Heterogeneity of endothelial cells. Specific markers. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[25]  A. Malik,et al.  Protein Kinase C-α Signals Rho-Guanine Nucleotide Dissociation Inhibitor Phosphorylation and Rho Activation and Regulates the Endothelial Cell Barrier Function* , 2001, The Journal of Biological Chemistry.

[26]  K. Aktories.  Bacterial toxins that target Rho proteins. , 1997, The Journal of clinical investigation.

[27]  R B Wysolmerski,et al.  Myosin light chain kinase-regulated endothelial cell contraction: the relationship between isometric tension, actin polymerization, and myosin phosphorylation , 1995, The Journal of cell biology.

[28]  A. Verin,et al.  Introduction of C3 exoenzyme into cultured endothelium by lipofectamine. , 2000, Analytical biochemistry.

[29]  P. Lelkes,et al.  The thrombin receptor in adrenal medullary microvascular endothelial cells is negatively coupled to adenylyl cyclase through a Gi protein. , 1997, Biochimica et biophysica acta.

[30]  L. Brass,et al.  Protease-Activated G Protein-Coupled Receptors on Human Platelets and Endothelial Cells , 1997, Thrombosis and Haemostasis.

[31]  A. Verin,et al.  Regulation of Thrombin-Mediated Endothelial Cell Contraction and Permeability , 1996, Seminars in thrombosis and hemostasis.

[32]  A. Hall,et al.  Rho GTPases and their effector proteins. , 2000, The Biochemical journal.

[33]  Y. Zheng,et al.  Dbl family guanine nucleotide exchange factors. , 2001, Trends in biochemical sciences.

[34]  K. Kaibuchi,et al.  The COOH Terminus of Rho-kinase Negatively Regulates Rho-kinase Activity* , 1999, The Journal of Biological Chemistry.

[35]  A. Malik,et al.  Electrical method for detection of endothelial cell shape change in real time: assessment of endothelial barrier function. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[36]  F. Pavalko,et al.  Thrombin-mediated focal adhesion plaque reorganization in endothelium: role of protein phosphorylation. , 1997, American journal of respiratory cell and molecular biology.

[37]  S. Offermanns,et al.  Rho/Rho-kinase mediated signaling in physiology and pathophysiology , 2002, Journal of Molecular Medicine.

[38]  P Kouklis,et al.  Ca(2+) signalling and PKCalpha activate increased endothelial permeability by disassembly of VE-cadherin junctions. , 2001, The Journal of physiology.

[39]  T. Voyno-Yasenetskaya,et al.  Differential Expression of Adenosine Receptors in Human Endothelial Cells: Role of A2B Receptors in Angiogenic Factor Regulation , 2002, Circulation research.

[40]  P. Gallagher,et al.  Myosin light chain kinases , 1997, Journal of Muscle Research & Cell Motility.

[41]  R. Schaeffer,et al.  ROCK mediates thrombin's endothelial barrier dysfunction. , 2000, American journal of physiology. Cell physiology.

[42]  Markus Essler,et al.  Thrombin Inactivates Myosin Light Chain Phosphatase via Rho and Its Target Rho Kinase in Human Endothelial Cells* , 1998, The Journal of Biological Chemistry.

[43]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[44]  Fumio Matsumura,et al.  Phosphorylation of Myosin-Binding Subunit (Mbs) of Myosin Phosphatase by Rho-Kinase in Vivo , 1999, The Journal of cell biology.

[45]  E. Dejana,et al.  Perspectives Series: Cell Adhesion in Vascular Biology Endothelial Adherens Junctions: Implications in the Control of Vascular Permeability and Angiogenesis , 1996 .

[46]  Histamine alters cadherin-mediated sites of endothelial adhesion. , 1999, The American journal of physiology.

[47]  A. Malik,et al.  Mechanisms of increased endothelial permeability. , 1996, Canadian journal of physiology and pharmacology.

[48]  H. Davis,et al.  Regulation of endothelial cell gap formation and barrier dysfunction: Role of myosin light chain phosphorylation , 1995, Journal of cellular physiology.

[49]  A. Barr,et al.  Reconstitution of Receptors and GTP-binding Regulatory Proteins (G Proteins) in Sf9 Cells , 1997, The Journal of Biological Chemistry.

[50]  A. Malik,et al.  Thrombin-induced alterations in lung fluid balance in awake sheep. , 1985, Journal of applied physiology.

[51]  John G. Collard,et al.  Activation of RhoA by Thrombin in Endothelial Hyperpermeability: Role of Rho Kinase and Protein Tyrosine Kinases , 2000, Circulation research.

[52]  K. Kaibuchi,et al.  Formation of Actin Stress Fibers and Focal Adhesions Enhanced by Rho-Kinase , 1997, Science.

[53]  J. Garcia,et al.  Regulation of endothelial cell myosin light chain kinase by Rho, cortactin, and p60 src. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[54]  K. Kaibuchi,et al.  Myosin II activation promotes neurite retraction during the action of Rho and Rho‐kinase , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[55]  Y. Takuwa.  Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors. , 2002, Biochimica et biophysica acta.

[56]  W D Niles,et al.  Time course of recovery of endothelial cell surface thrombin receptor (PAR-1) expression. , 1999, The American journal of physiology.

[57]  V. Natarajan,et al.  Thrombin stimulation of human endothelial cell phospholipase D activity. Regulation by phospholipase C, protein kinase C, and cyclic adenosine 3'5'-monophosphate. , 1992, Blood.

[58]  B. Nilius,et al.  RhoA exerts a permissive effect on volume-regulated anion channels in vascular endothelial cells. , 2002, American journal of physiology. Cell physiology.

[59]  Yoshiharu Matsuura,et al.  Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-kinase)* , 1996, The Journal of Biological Chemistry.

[60]  Kozo Kaibuchi,et al.  Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase) , 1996, Science.

[61]  P. Cohen,et al.  Phosphorylation of the regulatory subunit of smooth muscle protein phosphatase 1M at Thr850 induces its dissociation from myosin , 2002, FEBS letters.

[62]  J. Aschner,et al.  Thrombin receptor activating peptides induce Ca2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet‐derived growth factor mRNA expression in cultured endothelium , 1993, Journal of cellular physiology.

[63]  A. Hall,et al.  Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. , 2002, Genes & development.

[64]  K. Shitara,et al.  Heterogeneity of the signal transduction pathways for VEGF‐induced MAPKs activation in human vascular endothelial cells , 2001, Journal of cellular physiology.

[65]  J. Stull,et al.  Activation of smooth muscle contraction: relation between myosin phosphorylation and stiffness. , 1986, Science.